Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 476K | 0.05 | $ 10.39M |
3/31/2025 | $ 898K | 0.09 | $ 9.77M |
12/31/2024 | $ 1.7M | 0.18 | $ 9.54M |
9/30/2024 | $ 915K | 0.09 | $ 10.1M |
6/30/2024 | $ 3.55M | 0.4 | $ 8.84M |
3/31/2024 | $ 3.29M | 0.33 | $ 9.88M |
12/31/2023 | $ 5.44M | 0.63 | $ 8.65M |
9/30/2023 | $ 15.26M | 3.24 | $ 4.72M |
6/30/2023 | $ 21.04M | 7.29 | $ 2.88M |
3/31/2023 | $ 23.39M | 12.74 | $ 1.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for AIM IMMUNOTECH INC is calculated as follows: CashnEq [ $ 38.5M ] / LiabilitesC [ $ 795K ]
(=) Cash Ratio [ 48.42 ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |